CliffBio
small molecule

QUILLICHEW ER

METHYLPHENIDATE HYDROCHLORIDE

Loss of exclusivityAugust 2033latest FDA-listed patent expiry
CompanyNextWave Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameQUILLICHEW ER
Active ingredientMETHYLPHENIDATE HYDROCHLORIDE
Strength30MG
Dosage formTABLET, EXTENDED RELEASE, CHEWABLE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2015
Marketing statusRX

Listed patents

PatentExpiresType
9545399August 2033product
9844544August 2033product
11103495August 2033product
9295642August 2033product
10857143August 2033product
8999386August 2033product
11633389August 2033product
11103494August 2033product
8287903February 2031product
8202537March 2027product

More from NextWave Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

QUILLICHEW ER patent cliff — loss of exclusivity August 2033 | CliffBio